The co-occurrence of IgG4-related disease and malignancy: insights from a prospective cohort study

IgG4-RD patients exhibit an elevated risk of specific malignancies, particularly lymphoma, with elevated ESR and greater organ involvement identified as significant risk factors for malignancy development during follow-up period.